الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
81 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
82 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Hanaan Ahmed Mohammed Ahmed 2021
83 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Asmaa salah ibrahim mohammed 2021
84 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

 		Dr. Amen Hamdy Zaki Ali 2020
85 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Sanaa Saber Abdelraheem Barakat 2020
86 Expression of Estrogen receptor beta in Squamous cell carcinoma of bladder cancer Dr. Amen Hamdy Zaki Ali 2020
87 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Abeer Elsayed Ali Ibrahim 2020
88 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		Sanaa Saber Abdelraheem Barakat 2020
89 Adipocytokine, leptin, and resistin in combination with quantitative visceral adiposity as predictors of colorectal neoplasm: A case-control study Dr. Salah Mabrouk Khallaf Abd Rabou 2020
90 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		Prof. Ashraf Zeidan Abdalla Ahmed 2020